The Department of Rehabilitation and Regenerative Medicine is committed to innovative translational stem cell research.
Columbia has over 100 stem cell laboratories performing stem cell research in areas including bioengineering, blood, bone/teeth, brain, cancer, diabetes, internal organs, neurodegeneration, skin and stem cell biology. The Columbia Stem Cell Initiative is committed to exploring a broad range of potential stem cell applications, including disease modeling, screening for small molecule drug therapies, enhancement of endogenous stem cell function to enhance tissue repair, and regenerative therapies.
CSCI research faculty within the Department of Rehabilitation and Regenerative Medicine include:
- Hynek Wichterle, PhD
- Lei Ding, PhD
- Masayuki Yazawa, PhD
- Edmund Au, PhD
- Barbara Corneo, PhD
- Joanna Smeeton, PhD
The Director of the CSCI is Emmanuelle Passegue, PhD.
For more information on CSCI, please contact:
- Lalena Luna, Executive Assistant
Columbia Stem Cell Initiative (CSCI)
701 West 168th Street
Hammer Health Sciences Center, HHSC-702
New York, NY 10032